Claims
- 1. Isolated, dimeric FAP.alpha. molecule, having a molecular weight of about 170 kilodaltons as determined by SDS-PAGE, wherein said dimeric FAP.alpha. molecule is capable of degrading extracellular matrix proteins.
- 2. The dimeric FAP.alpha. molecule of claim 1, wherein each monomer of said dimeric FAP.alpha. molecule consists of the amino acid sequence of SEQ ID NO: 2.
- 3. The dimeric FAP.alpha. molecule of claim 1, produced recombinantly.
- 4. The dimeric FAP.alpha. molecule of claim 3, produced by a eukaryotic cell.
RELATED APPLICATION
This application is a continuation-in-part of Ser. No. 08/230,491, filed Apr. 20, 1994, now U.S. Pat. No. 5,587,299 and incorporated by reference.
Foreign Referenced Citations (1)
Number |
Date |
Country |
WO9529233 |
Nov 1995 |
WOX |
Non-Patent Literature Citations (4)
Entry |
Rettig et al., "Fibroblast Activitation Protein: Purification, Epitope Mapping and Induction By Growth Factors", Int. J. Cancer 58: 385-392 (1994). |
Rettig et al., "Regulation and Heterodimeric Structure of the Fibroblast Activation Protein in Normal and Transformed Cells of Mesenchymal and Neuroectodermal Origin", Can. Res. 53: 3327-3335 (Jul. 15, 1993). |
Rettig et al., Cell Surface Glycoprotein of Human Sarcomas: Differential Expression in Normal and Malignant Tissues and Cultured Cells, Proc. Natl. Acad. Sci. USA 85: 3110-3114 (May 1988). |
Aruffo et al., "Molecular Cloning of a CD28 cDNA by a High-efficiency COS Cell Expression System", Proc. Natl. Acad. Sci. USA 84: 8573-8577 (Dec. 1987). |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
230491 |
Apr 1994 |
|